financetom
Business
financetom
/
Business
/
Harley-Davidson's Q2 Earnings, Revenue Drop; Full-Year Guidance Still Withheld
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Harley-Davidson's Q2 Earnings, Revenue Drop; Full-Year Guidance Still Withheld
Jul 30, 2025 5:29 AM

08:12 AM EDT, 07/30/2025 (MT Newswires) -- Harley-Davidson ( HOG ) reported Q2 earnings Wednesday of $0.88 per diluted share, down from $1.63 a year earlier.

Analysts polled by FactSet expected $0.96.

Revenue for the quarter ended June 30 was $1.31 billion, down from $1.62 billion a year earlier.

Analysts surveyed by FactSet expected $1.1 billion.

The company said it continues to withhold its 2025 guidance, due to the uncertainty surrounding the 'global tariff and business outlook.'

The company's shares were up nearly 9% in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%
Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%
Apr 16, 2024
Calidi Biotherapeutics Inc ( CLDI ) shares are trading lower by 59% to $0.25 during Tuesday’s session after the company announced the pricing of a $6.1 million public offering. The offering includes various types of warrants with different exercise prices and expiration dates. The company plans to use the net proceeds for working capital, general corporate purposes, and pre-clinical and...
Why Jaguar Health Stock Is Up Today
Why Jaguar Health Stock Is Up Today
Apr 16, 2024
Jaguar Health, Inc. ( JAGX ) shares are trading higher Tuesday after the company announced it has signed an exclusive 5-year in-license agreement with Venture Life Group PLC. The Details: The license agreement is for the U.S. market for Venture Life's FDA-approved prescription product, Gelclair. Gelclair is used for the treatment of oral mucositis, also called “chemo mouth.”  “We are...
Climate target group in turmoil over carbon offsetting plan
Climate target group in turmoil over carbon offsetting plan
Apr 16, 2024
(Corrects attribution in penultimate paragraph to McKinsey) By Simon Jessop LONDON (Reuters) -Staff at the Science Based Targets initiative (SBTi) on Wednesday called for the ouster of the global nonprofit's chief executive and the reversal of a plan to allow companies to use carbon credits to offset greenhouse gas emissions from their value chain. The staff accused SBTi's leadership of...
IMF warns financial risks linger amid 'soft landing'
IMF warns financial risks linger amid 'soft landing'
Apr 16, 2024
WASHINGTON (Reuters) - The International Monetary Fund is cautioning against overexuberance in markets as investors look for central bankers to pull off a soft landing in their years-long inflation battle. In its latest semi-annual Global Financial Stability Report, the IMF noted that markets have turned quite optimistic since the October edition, when investors were still recovering from spring turmoil in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved